Literature DB >> 28632958

Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.

Jonathan G Stine1, Jennifer Wang2, Puja M Shah3, Curtis K Argo1, Nicolas Intagliata1, Andre Uflacker4, Stephen H Caldwell1, Patrick G Northup1.   

Abstract

BACKGROUND & AIMS: Portal vein thrombosis (PVT) in cirrhosis may lead to hepatic decompensation and increased mortality. We aimed to investigate if decreased portal vein (PV) velocity is associated with future PVT.
METHODS: Data on adult patients with cirrhosis and PVT between January 1, 2005 and July 30, 2015 were obtained. Cases with PVT were matched by age, gender and Model for End-stage Liver Disease (MELD) score to corresponding controls without PVT. Cox proportional hazards models, receiver operator curves and Kaplan Meier curves were constructed.
RESULTS: One hundred subjects (50 matched pairs) with mean age 53.8±13.1 y and MELD score 14.9±5.5 were included in our analysis. Sixty-four percent were male and 76% were Child-Turcotte-Pugh Class A or B. Baseline characteristics (prior to development of PVT) were similar, except for baseline PV velocity (16.9 cm/s, 95% CI 13.9-20.0 PVT vs 25.0, 95% CI 21.8-28.8 no PVT, P<.001). 30 PVT subjects had PV velocity <15 cm/s compared to five without PVT (P<.001). On adjusted multivariable analysis, PV velocity was the strongest independent risk factor predicting PVT development (HR 0.86, 95% CI 0.80-0.93). The predictive value for PVT development was greatest for flow <15 cm/s (c-statistic 0.77). PV velocity <15 cm/s had a highly significant association with future PVT (HR 6.00, 95% CI 2.20-16.40, P=<.001).
CONCLUSIONS: Decreased PV velocity is associated with increased risk of future PVT. Patients with cirrhosis and decreased PV velocity are a high-risk subgroup that warrants further investigation with prospective study.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cirrhosis; coagulopathy; prohaemostasis; thrombosis

Mesh:

Year:  2017        PMID: 28632958     DOI: 10.1111/liv.13500

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  31 in total

Review 1.  Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.

Authors:  Jonathan G Stine; Patrick G Northup
Journal:  Dig Dis Sci       Date:  2019-03       Impact factor: 3.199

Review 2.  Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.

Authors:  Xiangbo Xu; Xiaozhong Guo; Valerio De Stefano; Gilberto Silva-Junior; Hemant Goyal; Zhaohui Bai; Qingchun Zhao; Xingshun Qi
Journal:  Hepatol Int       Date:  2019-06-07       Impact factor: 6.047

Review 3.  Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?

Authors:  Margaret Spinosa; Jonathan G Stine
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

4.  Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.

Authors:  Martin Rössle; Michael Schultheiss
Journal:  J Transl Int Med       Date:  2018-03-28

5.  Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index.

Authors:  Daniel Gaballa; Dmitri Bezinover; Zakiyah Kadry; Elaine Eyster; Ming Wang; Patrick G Northup; Jonathan G Stine
Journal:  Liver Transpl       Date:  2019-09-19       Impact factor: 5.799

Review 6.  Narrative review of portal vein thrombosis in cirrhosis: pathophysiology, diagnosis, and management from an interventional radiology perspective.

Authors:  Sameer Gadani; Sasan Partovi; Abraham Levitin; Nicholas Zerona; Shreya Sengupta; Giuseppe D'Amico; Teresa Diago Uso; K V Narayanan Menon; Cristiano Quintini
Journal:  Cardiovasc Diagn Ther       Date:  2022-02

Review 7.  Portal Vein Thrombosis In Cirrhosis: Interventional Treatment Options.

Authors:  Christopher Molvar; Parag Amin
Journal:  Curr Gastroenterol Rep       Date:  2021-10-15

8.  Metabolic Disorders and Risk of Portal Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Jiao Li; Qiong Wang; Mei Yang; Xiaobin Sun
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

9.  Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.

Authors:  Lydia Giannitrapani; Walter Granà; Anna Licata; Cosima Schiavone; Giuseppe Montalto; Maurizio Soresi
Journal:  Med Princ Pract       Date:  2018-08-14       Impact factor: 1.927

Review 10.  Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai).

Authors: 
Journal:  J Dig Dis       Date:  2021-03-07       Impact factor: 2.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.